CORC  > 中南大学
ERCC1 Cys8092Ala and XRCC1 Arg399Gln Polymorphisms Predict Progression-Free Survival after Curative Radiotherapy for Nasopharyngeal Carcinoma
Jin, Hekun; Xie, Xiaoxue; Wang, Hui; Hu, Jun; Liu, Feng; Liu, Zhigang; Zhou, Jumei; Zhang, Yingying; Xi, Xuping; Hu, Bingqiang
刊名PLOS ONE
2014
卷号9期号:7页码:e101256
关键词Radiation therapy,DNA repair,Cancer treatment,Nasopharyngeal carcinoma,Variant genotypes,DNA damage,Heredity,Multivariate analysis
ISSN号1932-6203
DOI10.1371/journal.pone.0101256
URL标识查看原文
WOS记录号WOS:000339992400012
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/3339829
专题中南大学
作者单位1.[Jin, Hekun
2.Liao, Yuping
3.Zhang, Yingying] Cent S Univ, Xiangya Hosp, Dept Radiat Oncol, Changsha, Hunan, Peoples R China.
推荐引用方式
GB/T 7714
Jin, Hekun,Xie, Xiaoxue,Wang, Hui,et al. ERCC1 Cys8092Ala and XRCC1 Arg399Gln Polymorphisms Predict Progression-Free Survival after Curative Radiotherapy for Nasopharyngeal Carcinoma[J]. PLOS ONE,2014,9(7):e101256.
APA Jin, Hekun.,Xie, Xiaoxue.,Wang, Hui.,Hu, Jun.,Liu, Feng.,...&Tang, Jingtian*.(2014).ERCC1 Cys8092Ala and XRCC1 Arg399Gln Polymorphisms Predict Progression-Free Survival after Curative Radiotherapy for Nasopharyngeal Carcinoma.PLOS ONE,9(7),e101256.
MLA Jin, Hekun,et al."ERCC1 Cys8092Ala and XRCC1 Arg399Gln Polymorphisms Predict Progression-Free Survival after Curative Radiotherapy for Nasopharyngeal Carcinoma".PLOS ONE 9.7(2014):e101256.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace